Obstetrics & Gynecology

Medicine & Life Sciences

1. Action Potentials 10%
2. Advisory Committees 10%
3. Amnion 12%
4. Amniotic Fluid 25%
5. Apamin 12%
6. Arterial Pressure 10%
7. Assisted Reproductive Techniques 16%
8. Atrial Natriuretic Factor 11%
9. Blood Volume 12%
10. Body Mass Index 14%
11. Calcium-Activated Potassium Channels 12%
12. Cesarean Section 12%
13. Cohort Studies 15%
14. Confidence Intervals 30%
15. Contraception 40%
16. Contraceptive Agents 45%
17. Contraceptives, Oral, Combined 10%
18. Cost-Benefit Analysis 21%
19. Costs and Cost Analysis 18%
20. Counseling 9%
21. Dilatation 10%
22. Embryonic Structures 9%
23. Endometriosis 11%
24. estradiol valerate-dienogest 13%
25. Estrogens 13%
26. Extraembryonic Membranes 10%
27. Fertility 10%
28. Fertilization in Vitro 14%
29. Fetal Blood 9%
30. Fetal Death 13%
31. Fetal Movement 9%
32. Fetus 45%
33. First Pregnancy Trimester 19%
34. Genes 11%
35. Gestational Age 28%
36. Gestational Diabetes 21%
37. Health 9%
38. Hemodynamics 17%
39. Hemorrhage 18%
40. Hormonal Contraception 14%
41. Hormones 17%
42. Hypoxia 14%
43. Incidence 9%
44. Induced Labor 18%
45. Infertility 11%
46. Intrauterine Devices 16%
47. Levonorgestrel 20%
48. Logistic Models 9%
49. Macaca mulatta 13%
50. Menorrhagia 12%
51. Misoprostol 10%
52. Morbidity 14%
53. Mothers 60%
54. Neoplasms 9%
55. Newborn Infant 12%
56. Obesity 14%
57. Obstetrics 32%
58. Odds Ratio 28%
59. Oocytes 28%
60. Oral Contraceptives 28%
61. Ovarian Epithelial Carcinoma 28%
62. Ovarian Neoplasms 38%
63. Ovulation Induction 9%
64. Pain 13%
65. Parturition 25%
66. Pelvic Floor 12%
67. Physicians 10%
68. Placebos 15%
69. Placenta 18%
70. Population 12%
71. Postpartum Hemorrhage 12%
72. Postpartum Period 23%
73. Pre-Eclampsia 22%
74. Pregnancy 100%
75. Pregnancy Outcome 18%
76. Pregnancy Rate 10%
77. Pregnant Women 17%
78. Premature Birth 23%
79. Premature Obstetric Labor 14%
80. Prenatal Care 9%
81. Primates 22%
82. Progesterone 10%
83. Proteins 10%
84. Randomized Controlled Trials 19%
85. Retrospective Studies 11%
86. Safety 15%
87. Second Pregnancy Trimester 10%
88. Serum 14%
89. Sheep 56%
90. Small-Conductance Calcium-Activated Potassium Channels 10%
91. Systematic Reviews 19%
92. Therapeutics 16%
93. Trial of Labor 9%
94. Tubal Sterilization 12%
95. Umbilical Arteries 14%
96. Urinary Incontinence 15%
97. Vaginal Birth after Cesarean 12%
98. Vascular Endothelial Growth Factor A 14%
99. Vulvodynia 11%
100. Watchful Waiting 13%